TransMedics Group, Inc.TMDXNASDAQ
Loading
Revenue Growth Recovery in ProgressRecovering
Percentile Rank31
3Y CAGR-19.0%
5Y CAGR+9.3%
Year-over-Year Change
Year-over-year revenue growth rate
3Y CAGR
-19.0%/yr
vs -6.1%/yr prior
5Y CAGR
+9.3%/yr
Recent deceleration
Acceleration
-12.9pp
Decelerating
Percentile
P31
Within normal range
vs 5Y Ago
1.6x
Solid growth
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 11.78% |
| Q3 2025 | -8.61% |
| Q2 2025 | 9.64% |
| Q1 2025 | 18.02% |
| Q4 2024 | 11.83% |
| Q3 2024 | -4.85% |
| Q2 2024 | 18.02% |
| Q1 2024 | 19.31% |
| Q4 2023 | 22.19% |
| Q3 2023 | 26.62% |
| Q2 2023 | 26.26% |
| Q1 2023 | 32.44% |
| Q4 2022 | 22.16% |
| Q3 2022 | 25.15% |
| Q2 2022 | 29.23% |
| Q1 2022 | 64.25% |
| Q4 2021 | 80.04% |
| Q3 2021 | -34.28% |
| Q2 2021 | 15.85% |
| Q1 2021 | -7.53% |
| Q4 2020 | 7.56% |
| Q3 2020 | 109.11% |
| Q2 2020 | -54.97% |
| Q1 2020 | 24.32% |
| Q4 2019 | -15.93% |
| Q3 2019 | 27.16% |
| Q2 2019 | 21.17% |
| Q1 2019 | 31.94% |
| Q4 2018 | -12.26% |
| Q3 2018 | 38.56% |
| Q2 2018 | 15.72% |
| Q1 2018 | 19.61% |
| Q4 2017 | 12.80% |
| Q3 2017 | -16.35% |
| Q3 2017 | 20.26% |
| Q2 2017 | 0.00% |